Signal
Milken Institute Identifies Nine Critical Reimbursement Barriers Stalling Women's Health Innovation Adoption
- Category
- · Report · Global
- Date
- August 25, 2026
- Source
- OVUM
Summary
A new report from the Milken Institute’s Women’s Health Network details how fragmented payer pathways and sex-specific evidence gaps are hindering the commercialization of femtech. This framework serves as a roadmap for stakeholders navigating the complex transition from clinical validation to scalable market access.
The report adds hard numbers — market size, share, and economics — for Care Delivery. Check the method and the data year before using the numbers.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.